Middletown, DE -- (SBWIRE) -- 08/19/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: Endo Health Solutions Inc (NASDAQ:ENDP), Cognizant Technology Solutions Corp (NASDAQ:CTSH), Warner Chilcott Plc (NASDAQ:WCRX), Hologic, Inc. (NASDAQ:HOLX).
Endo Health Solutions Inc (NASDAQ:ENDP) closed at the price of $36.81, after opening at $37.49. During the previous session, the company’s minimum price was $36.21, while it touched its highest price for the day at $37.62. ENDP’s beta value stands at 0.75 points. Endo Health Solutions Inc. provides specialty healthcare solutions in the United States and internationally. The company?s Endo Pharmaceuticals segment offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar, and Fortesta Gel for pain, urology, endocrinology, and oncology.
Has ENDP Found The Bottom and Ready To Move Up? Find Out Here
Cognizant Technology Solutions Corp (NASDAQ:CTSH) reported the increase of 0.85%, to close at $71.46. Its beta value stands at 1.13 times and Cognizant Technology Solutions Company’s earnings per share was $3.75. Cognizant Technology Solutions Corp (NASDAQ:CTSH) has the total of 301.37 million outstanding shares. Cognizant Technology Solutions Corporation provides information technology (IT), consulting, and business process outsourcing services worldwide. The company operates through four segments: Financial Services; Healthcare; Manufacturing, Retail, and Logistics; and Other.
For How Long CTSH’s Gloss will Attract Investors? Find out via this report
Warner Chilcott Plc (NASDAQ:WCRX) stock on Friday decreased -0.09% and finished the day at $21.39. The 52 week range of the stock remained $10.85 - $22.08. Warner Chilcott's earnings per share is $1.82, while its beta value stands at 1.26 times. Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the women?s healthcare, gastroenterology, urology, and dermatology markets.
Why Should Investors Buy WCRX After the Recent Fall? Just Go Here and Find Out
Hologic, Inc. (NASDAQ:HOLX) traded with a plunge of -0.04% and closed at $22.63. Its opening price was $22.60. Hologic Company's earnings per share is $-0.51, while its beta value stands at 1.21 times. Hologic, Inc. develops, manufactures, and supplies diagnostics, medical imaging systems, and surgical products for women. The company’s Breast Health segment offers full field digital mammography, C-View, screen-film mammography, computer aided detection, Trident specimen radiography, and stereotactic breast biopsy systems; healthcome mammography, breast biopsy, and breast brachytherapy products.
Will HOLX Get Buyers Even After The Recent Rally? Find Out Here
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!
Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.
VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.
Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)